Neuberger Berman Group LLC Sells 45,522 Shares of Boston Scientific Corporation (BSX)
Neuberger Berman Group LLC trimmed its stake in Boston Scientific Corporation (NYSE:BSX) by 1.9% during the third quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 2,354,170 shares of the medical equipment provider’s stock after selling 45,522 shares during the quarter. Neuberger Berman Group LLC owned approximately 0.17% of Boston Scientific worth $68,671,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors also recently modified their holdings of the company. Swiss National Bank grew its holdings in shares of Boston Scientific by 2.9% in the 2nd quarter. Swiss National Bank now owns 5,584,930 shares of the medical equipment provider’s stock worth $154,814,000 after acquiring an additional 156,800 shares during the last quarter. Wells Fargo & Company MN grew its holdings in shares of Boston Scientific by 10.5% during the second quarter. Wells Fargo & Company MN now owns 9,157,768 shares of the medical equipment provider’s stock valued at $253,854,000 after buying an additional 867,983 shares in the last quarter. Sit Investment Associates Inc. grew its holdings in shares of Boston Scientific by 37.8% during the third quarter. Sit Investment Associates Inc. now owns 141,710 shares of the medical equipment provider’s stock valued at $4,134,000 after buying an additional 38,855 shares in the last quarter. Greenwood Capital Associates LLC grew its holdings in shares of Boston Scientific by 71.7% during the third quarter. Greenwood Capital Associates LLC now owns 91,579 shares of the medical equipment provider’s stock valued at $2,671,000 after buying an additional 38,249 shares in the last quarter. Finally, Los Angeles Capital Management & Equity Research Inc. grew its holdings in shares of Boston Scientific by 35,016.2% during the second quarter. Los Angeles Capital Management & Equity Research Inc. now owns 3,042,464 shares of the medical equipment provider’s stock valued at $84,337,000 after buying an additional 3,033,800 shares in the last quarter. Institutional investors and hedge funds own 90.57% of the company’s stock.
In other Boston Scientific news, EVP Timothy A. Pratt sold 10,000 shares of the business’s stock in a transaction dated Friday, December 1st. The stock was sold at an average price of $26.04, for a total value of $260,400.00. Following the completion of the sale, the executive vice president now owns 154,681 shares of the company’s stock, valued at $4,027,893.24. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, insider Valley Gold Master Fund L. Sun purchased 408,006 shares of Boston Scientific stock in a transaction on Tuesday, November 28th. The stock was bought at an average cost of $0.45 per share, with a total value of $183,602.70. In the last three months, insiders have sold 424,698 shares of company stock valued at $12,273,553. Insiders own 0.74% of the company’s stock.
Shares of Boston Scientific Corporation (BSX) opened at $25.78 on Monday. The stock has a market capitalization of $35,401.00, a price-to-earnings ratio of 21.13, a P/E/G ratio of 1.99 and a beta of 0.96. Boston Scientific Corporation has a 12-month low of $21.29 and a 12-month high of $29.93. The company has a current ratio of 0.72, a quick ratio of 0.50 and a debt-to-equity ratio of 0.58.
Boston Scientific (NYSE:BSX) last released its quarterly earnings data on Thursday, October 26th. The medical equipment provider reported $0.31 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.31. The firm had revenue of $2.22 billion during the quarter, compared to analysts’ expectations of $2.21 billion. Boston Scientific had a return on equity of 23.60% and a net margin of 9.55%. The business’s revenue for the quarter was up 5.6% on a year-over-year basis. During the same quarter last year, the firm earned $0.27 earnings per share. equities analysts forecast that Boston Scientific Corporation will post 1.25 EPS for the current year.
About Boston Scientific
Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company offers its products by seven businesses: Interventional Cardiology, Cardiac Rhythm Management, Endoscopy, Peripheral Interventions, Urology and Pelvic Health, Neuromodulation, and Electrophysiology.
Receive News & Ratings for Boston Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Boston Scientific and related companies with MarketBeat.com's FREE daily email newsletter.